Impact of Coverage of GLP-1 Drugs for Obesity on Medicare Expenditure s Source: JAMA Health Forum Hwang, April 25, 2025 Researchers in JAMA Health Forum used a microsimulation model to assess the likely financial results of Medicare covering GLP-1 drugs for obesity
Long-Term Wellness and the Post-Medication Phase For many, semaglutide is a tool to reach a specific health goal, but the ultimate objective is long-term, sustainable wellness
The following were the key findings of the study: Baseline sperm quality in the study cohort was poor, with parameters falling below the 5th percentile of reference values
If you are keen to know what BMI qualifies for weight loss medication, we will unpack everything you need to know about BMI and weight loss treatment in this guide
Want to skip ahead and get started on your weight loss journey right now
Its generally safe when prescribed, though common side effects include nausea, vomiting, or diarrhea, and its not recommended for people with a history of certain thyroid cancers or pancreatitis
